CClinicalTrials.gg
CompletedNCT07437443Updated Apr 23, 2026

Burnout, Secondary Traumatic Stress and Inflammatory Biomarkers in ICU Healthcare Workers

An observational study in Burnout, Secondary Traumatic Stress and Occupational Stress, sponsored by Elazıg Fethi Sekin Sehir Hastanesi. Completed at 1 site in Turkey (Türkiye). Per ClinicalTrials.gov, last updated 2026-04-23.

Sponsored by Elazıg Fethi Sekin Sehir Hastanesi · Observational

Study type
Observational
Model
Other
Time perspective
Cross-sectional
Enrollment
140
Sex
All
01

Study summary

Healthcare professionals working in intensive care units (ICUs) are frequently exposed to high levels of psychological stress due to critically ill patients, frequent encounters with death, complex clinical decision-making, and prolonged working hours. This environment increases the risk of burnout and secondary traumatic stress, which may not only affect mental well-being but also have measurable physiological consequences.

Emerging evidence suggests that chronic psychological stress and burnout may influence immune function through activation of proinflammatory pathways. Elevated levels of inflammatory biomarkers such as C-reactive protein (CRP), interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-α), and neutrophil-to-lymphocyte ratio (NLR) have been associated with stress-related conditions. However, data examining the relationship between burnout, secondary traumatic stress, and inflammatory biomarkers in intensive care healthcare workers remain limited.

This cross-sectional observational study aims to investigate the association between burnout and secondary traumatic stress levels, assessed using validated psychometric instruments (Maslach Burnout Inventory and Professional Quality of Life Scale), and inflammatory biomarkers (CRP, IL-6, TNF-α, and NLR) in ICU healthcare workers. Blood samples will be obtained in conjunction with routine annual health screening, and additional serum samples will be collected for biomarker analysis. The study seeks to clarify the psychoneuroimmunological mechanisms underlying occupational stress in critical care settings.

02

Conditions studied

  • Burnout
  • Secondary Traumatic Stress
  • Occupational Stress
  • Inflammation
  • Critical Care Staff

Keywords

  • Burnout
  • Secondary Traumatic Stress
  • Intensive Care Unit
  • Healthcare Workers
  • Interleukin-6
  • TNF-alpha
03

In context

Burnout, Psychological

442 studies on the registry are indexed under Burnout, Psychological; 106 are open to participants now.

This study's enrollment of 140 is below the median of 206 across 113 observational studies indexed under Burnout, Psychological.

Browse Burnout, Psychological studies →

Lead sponsor

Elazıg Fethi Sekin Sehir Hastanesi is the lead sponsor of 29 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

The study population consists of healthcare professionals working in intensive care units (anesthesia, internal medicine, and chest diseases ICUs) at Elazığ Fethi Sekin City Hospital. Participants include physicians, nurses, anesthesia technicians, and other healthcare staff who are actively involved in the care of critically ill patients. All participants are adults undergoing routine annual occupational health screening and voluntarily agree to participate in the study.

Inclusion criteria

  • Age ≥18 years

Active employment in an intensive care unit (anesthesia, internal medicine, or chest diseases ICU)

Participation in routine annual occupational health screening

Willingness to provide additional blood sample for research purposes

Voluntary participation with written informed consent

Exclusion criteria

Exclusion Criteria:

  • Active infection at the time of assessment

Use of systemic steroids, immunosuppressive agents, or chemotherapy within the last 4 weeks

Known autoimmune or rheumatologic disease

Hematologic malignancy or severe hematologic disorder

Pregnancy

Refusal to provide additional blood sample

Incomplete questionnaire data

05

Study design

Observational model
Other
Time perspective
Cross-sectional
Enrollment
140 participants (actual)
Patient registry
No

Groups and cohorts

  • ICU Healthcare Workers

    Healthcare professionals aged 18 years and older working in intensive care units (anesthesia, internal medicine, and chest diseases ICUs) who voluntarily participate in the study. Participants will complete validated psychometric scales assessing burnout and secondary traumatic stress, and blood samples will be collected for inflammatory biomarker analysis.

    Other: Psychometric Assessment and Blood Sampling

Interventions

  • OtherPsychometric Assessment and Blood Sampling

    Administration of validated burnout and secondary traumatic stress questionnaires and collection of blood samples for inflammatory biomarker analysis. No therapeutic or clinical intervention is performed.

06

What researchers measure

Primary outcomes

  1. Association Between Burnout Levels and Inflammatory Biomarkers

    Evaluation of the relationship between Maslach Burnout Inventory (MBI-HSS) total and subscale scores and inflammatory biomarker levels (CRP, IL-6, TNF-α, and NLR) using correlation and multivariable linear regression analysis.

    Time frame: At the time of assessment (single time point)

07

Study locations

1 site
  • Fethi Sekin City Hospital
    Elâzığ, Elâzığ 23100, Turkey (Türkiye)
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07437443
Lead sponsor
Elazıg Fethi Sekin Sehir Hastanesi
Responsible party
Sait Fatih Öner (Principal Investigator, Elazıg Fethi Sekin Sehir Hastanesi) — Principal investigator
First posted
Feb 27, 2026
Start date
Feb 23, 2026
Primary completion
Mar 1, 2026
Completion
Mar 10, 2026
Last update
Apr 23, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Apr 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion